中国
步伐
药物开发
抗癌药物
医学
公共卫生
药品审批
肿瘤科
临床肿瘤学
癌症治疗
家庭医学
药品
癌症
经济增长
环境卫生
政治学
内科学
药理学
地理
护理部
经济
法学
大地测量学
作者
Gaurav Bajaj,Manish Gupta,Hwei‐Gene Heidi Wang,Jeffrey S. Barrett,Matthew Tan,Katrin Rupalla,Richard Bertz,Jennifer Sheng
摘要
Cancer is a growing public health problem in China. Despite the high unmet medical need of patients with cancer in China, oncology drug approvals have historically lagged behind those in the West, mainly the United States and Europe. China is currently undertaking regulatory reforms at a fast pace in order to mitigate this lag.
科研通智能强力驱动
Strongly Powered by AbleSci AI